|
0
|
11
|
9n9nC |
Crystal structure of kras(g12c) bound to the cyclic peptide unc10415730a |
|
0
|
16
|
9i8wB |
Beta-catenin armadillo with cyclic peptide and compound 3 |
|
215
|
520
|
9i8wA |
Beta-catenin armadillo with cyclic peptide and compound 3 |
|
343
|
1049
|
9ni6A |
Cryo-em structure of the class 1 pi3k alpha/kras complex on popc/pops nanodiscs |
|
61
|
168
|
9ygsA |
Crystal structure of gmppnp bound kras-y71h in complex with rbd domain of craf(raf1) |
|
46
|
164
|
9yowB |
Crystal structure of gmppnp bound kras g12c in complex with cypa and rmc-4791 |
|
15
|
77
|
9ygsB |
Crystal structure of gmppnp bound kras-y71h in complex with rbd domain of craf(raf1) |
|
63
|
170
|
9yowA |
Crystal structure of gmppnp bound kras g12c in complex with cypa and rmc-4791 |
|
73
|
141
|
9ni6B |
Cryo-em structure of the class 1 pi3k alpha/kras complex on popc/pops nanodiscs |
|
56
|
171
|
9ni6C |
Cryo-em structure of the class 1 pi3k alpha/kras complex on popc/pops nanodiscs |
|
107
|
374
|
9suuA |
Usp28 usp domain in complex with t-10531 |
|
60
|
167
|
10nuA |
Structure of kras g12c bound to inhibitor 13ab |
|
61
|
166
|
10nvA |
Structure of kras g12c bound to inhibitor 13ba |
|
64
|
169
|
9pzfA |
Structure of kras g12c bound to compound 4 |
|
60
|
168
|
11qeA |
Crystal structure of gdp-bound kras g12d/i55e: suppressing g12d oncogenicity via second-site i55e mutation |
|
48
|
212
|
9pizI |
Structure of kras-g12c bound to 1-[(4ar,10p,13r)-10-[5-amino-4-fluoro-3-methyl-2-(trifluoromethyl)phenyl]-11-chloro-9-fluoro-1,2,4a,5-tetrahydropyrazino[1',2':4,5][1,4]oxazino[2,3-c]quinolin-3(4h)-yl]prop-2-en-1-one (compound 15) |
|
65
|
167
|
9pizA |
Structure of kras-g12c bound to 1-[(4ar,10p,13r)-10-[5-amino-4-fluoro-3-methyl-2-(trifluoromethyl)phenyl]-11-chloro-9-fluoro-1,2,4a,5-tetrahydropyrazino[1',2':4,5][1,4]oxazino[2,3-c]quinolin-3(4h)-yl]prop-2-en-1-one (compound 15) |
|
62
|
170
|
9pzyA |
Structure of kras g12c bound to divarasib (gdc6036) |
|
41
|
224
|
9pizH |
Structure of kras-g12c bound to 1-[(4ar,10p,13r)-10-[5-amino-4-fluoro-3-methyl-2-(trifluoromethyl)phenyl]-11-chloro-9-fluoro-1,2,4a,5-tetrahydropyrazino[1',2':4,5][1,4]oxazino[2,3-c]quinolin-3(4h)-yl]prop-2-en-1-one (compound 15) |
|
51
|
153
|
9zvuA |
The ubiquitin-associated domain of human thirty-eight negative kinase-1 rigidly fused to a double trigger variant of the 1tel crystallization chaperone, alternate crystal form |
|
59
|
169
|
9o0oA |
Crystal structure of gmppnp-bound wild type kras in complex with mrtx1133 |
|
62
|
169
|
9o0qA |
Crystal structure of gmppnp-bound mutant mras in complex with mrtx1133 |
|
62
|
168
|
9o0pA |
Crystal structure of gdp-bound mutant mras in complex with mrtx1133 |
|
69
|
169
|
9o0nA |
Crystal structure of gdp-bound wild type kras in complex with mrtx1133 |
|
62
|
167
|
9n44A |
Crystal structure of human kras-g12c covalent bound to olomorasib |
|
48
|
154
|
9z2lA |
The ubiquitin-associated domain of human thirty-eight negative kinase-1 rigidly fused to the 1tel crystallization chaperone |
|
65
|
169
|
9p46A |
Crystal structure of hras-g12d/q95h (gmppnp-bound) in complex with bbo-11818 |
|
198
|
1139
|
9hneB |
Cereblon in complex with ddb1, gspt1 and compound-1 |
|
22
|
195
|
9hneA |
Cereblon in complex with ddb1, gspt1 and compound-1 |
|
94
|
301
|
9j9dA |
Crystal structure of alk5 kinase domain in complex with inhibitor hm-279 |
|
32
|
94
|
9cdzA |
Crystal structure of mdm2-peptide complex |
|
188
|
477
|
9mjlA |
Sos1 in complex with an inhibitor |
|
50
|
153
|
9ngeA |
The ubiquitin-associated domain of human thirty-eight negative kinase-1 rigidly fused to a double trigger variant of the 1tel crystallization chaperone |
|
187
|
480
|
9mjmA |
Sos1 in complex with an inhibitor |
|
3
|
16
|
9cdzB |
Crystal structure of mdm2-peptide complex |
|
96
|
327
|
9frdA |
Wildtype egfr bound with compound 23 |
|
480
|
1705
|
9ce3A |
Structure of the tsc:wipi3 lysosomal recruitment complex |
|
69
|
238
|
9cplA |
The ubiquitin-associated domain of human thirty-eight negative kinase 1, fused to the 2tel crystallization chaperone via a 2-glycine linker |
|
63
|
166
|
8tlrA |
Crystal structure of human hras g12c covalently bound to amg 510 |
|
49
|
168
|
8piyA |
Nmr2 structure of kras g12v (gmppnp bound) in complex with (2e)-3-(1h-indol-2-yl)prop-2-enoic acid |
|
53
|
168
|
8pi0A |
Nmr2 structure of kras g12v (gmppnp bound) in complex with 5-(1h-indol-2-l)piperazin-2-one |
|
58
|
168
|
8cprA |
G13d mutant of kras4b (2-169) bound to gdp with the switch-i in fully open conformation crystallized in sodium potassium phosphate buffer |
|
66
|
219
|
8rndA |
Cathepsin s in complex with nnpi-c10 inhibitor |
|
66
|
219
|
8pi3A |
Cathepsin s y132d mutant in complex with nnpi-c10 inhibitor |
|
105
|
316
|
9gbeA |
Structure of human anaplastic lymphoma kinase (alk) harboring the g1202r/l1196m compound mutation in complex with nvl-655 |
|
103
|
276
|
9ce3E |
Structure of the tsc:wipi3 lysosomal recruitment complex |
|
256
|
966
|
9ce3C |
Structure of the tsc:wipi3 lysosomal recruitment complex |
|
0
|
12
|
9ce3G |
Structure of the tsc:wipi3 lysosomal recruitment complex |
|
76
|
305
|
9ce3F |
Structure of the tsc:wipi3 lysosomal recruitment complex |
|
64
|
209
|
9bd2A |
Mage-a3 mhd crystal soaked with kl861 |
